Factors in the feasibility and safety of outpatient robotic-assisted hysterectomy for endometrial or cervical carcinoma
Gynecologic Oncology Feb 09, 2020
Matern T, et al. - By performing this single-institution retrospective chart review, researchers defined factors impacting the feasibility as well as the safety of outpatient robotic-assisted hysterectomy for endometrial or cervical carcinoma. There were 254 patients who had a robotic hysterectomy for cervical or endometrial cancer between 2012 and 2016. Of these, a length of stay (LOS) > 12 h and a LOS < 12 h was reported for 150 (59.1%) and 104 (40.9%), respectively. Findings revealed the feasibility as well as the safety of performing robotic hysterectomy to treat endometrial and cervical carcinoma in the outpatient setting because successful discharge of > 40% of patients within 12 h was reported with no rise in readmission. Postoperative emesis, inadequate pain control, operating room time > 180 min, uterine mass > 150 g, start time after 15:00, history of venous thromboembolism (VTE), age > 75 years, BMI 35–40, and postoperative VTE formation, all were identified as factors that were related to a LOS > 12 h.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries